ArticleFrontiers in endocrinology2025
Extreme gradient boosting using conventional parameters accurately predicts insulin sensitivity in young and middle-aged Japanese persons.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study tested the hypothesis that insulin sensitivity (SI) can be estimated using machine learning (ML) based only on physical indicators or with the addition of lipid and fasting glucose levels. Methods: In 1,268 young (age <40 years, normal glucose tolerance; NGT) and 1,723 middle-aged Japanese persons with NGT (n=1,276) and glucose intolerance (n=447), the Matsuda index and the 1/homeostasis model assessment of insulin resistance were calculated as SI. In each group, SI was estimated by using eight ML methods, based only on physical indicators, as well as by using physical indicators together with lipid and fasting glucose levels. Moreover, 11 lipid-related estimates for SI were calculated. Results: Estimates by extreme gradient boosting showed the best correlations with SI indices among eight ML methods. According to feature importance and SHapley Additive exPlanations values, the contribution of each clinical factor to SI differed greatly by age and glucose tolerance status. Relationships of lipid-related estimates with SI were weaker than those of ML-derived estimates. Conclusions: It was possible to estimate SI using ML based only on physical indicators, or those with lipid and fasting glucose levels. The results also imply that it would be difficult to establish universal and robust estimates for SI using conventional parameters. Further validation studies are necessary in diverse ethnic groups with various body composition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.